FIELD: chemistry.
SUBSTANCE: invention relates to versions of a novel method of producing a dihydropyrimidine derivative of formula (I-2) or a tautomer thereof of formula (Ia-2). Invention also relates to a novel intermediate product for synthesis thereof of formula (V-2) for getting compound of formula (I-2) or its tautomer of formula (Ia-2). Compounds of formula (I-2) and formula (Ia-2) can be used for treating or relieving viral infection, particularly HBV infection, or diseases caused by HBV infection. Process of preparing a dihydropyrimidine compound of formula (I-2) or a tautomer thereof of formula (Ia-2)
(I-2) or (Ia-2), where each R1 is F; R2 is Cl or Br; R3 is C1-4 alkyl; Z is -S-; Y is -O-, -S-, -S(=O)t, -(CH2)q- or -N(R5)-; each t and q independently has value of 0, 1 or 2; R5 is H or C1-4 alkyl; each R6 independently represents H, halo, C1-4 alkyl, C1-4 haloalkyl, amine, C1-4 alkylamine, C1-4 alkoxy, nitro, triazolyl, tetrazole, -(CR7R7a)m-OH, -S(=O)qOR8a, -(CR7R7a)m-S(=O)qN(R8a)2, -(CR7R7a)t-N(R8a)2, -(CR7R7a)m-C(=O)O-R8, -(CR7R7a)m-C(=O)O-(CR7R7a)m-OC(=O)O-R8, -(CR7R7a)m-C(=O)O-(CR7R7a)m-OC(=O)-R8, -(CR7R7a)m-C(=O)O-(CR7R7a)m-C(=O)O-R8, -(CR7R7a)m-OC(=O)-R8 or -(CR7R7a)m-C(=O)-N(R8R8a); each R7a and R7 independently represents H, halo, C1-4 alkyl, C1-4 haloalkyl, -(CH2)m-OH or -(CH2)m-C(=O)OR8; each R8 and R8a independently represents H, C1-4 alkyl, amino-C1-4-alkyl, C1-4 alkoxy, C1-6 alkyl-S(=O)q-, C6-10 aryl, C1-9 heteroaryl, C3-6 cycloalkyl, C2-9 heterocyclyl, C6-10 aryl-C1-6-alkyl, C1-9 heteroaryl-C1-6-alkyl, C3-6 cycloalkyl-C1-4-alkyl, C2-9 heterocyclyl-C1-6-alkyl, C2-9 heterocyclyl-S(=O)q-, C1-9 heteroaryl-S (=O)q-, C3-6 cycloalkyl-S(=O)q-, C6-10 aryl-S(=O)q-, -(CH2)m-OH, -(CH2)m-C(=O)O-(CH2)m-H or -(CH2)m-OC(=O)-(CH2)m-H; n takes values of 0, 1, 2, 3, 4 or 5; each m independently assumes values of 0, 1, 2, 3 or 4; consists of following steps: step (A): reacting an amidine compound with formula (II-1)
,
or a salt thereof, and an aldehyde compound of formula (III-2)
and compounds with formula (IV)
,
to obtain a compound of formula (V-2)
where R1 independently represents F; R2 is Cl or Br; R3b is isopropoxy; R3a is H; Z is -S-; wherein reaction at step (A) is carried out at temperature from 25 to 154 °C, wherein step (A) further comprises cooling the compound of formula (V-2) obtained at step (A) to obtain a solid compound of formula (V-2) to a cooling temperature in the range of from -40 to 40 °C, step (B) comprises halogenating a compound of formula (V-2) to form a halide; and then reacting a halide and a compound of formula (VI)
or a salt thereof, to obtain a compound of formula (VII-2)
and step (C) consists in obtaining a compound of formula (I-2) or formula (Ia-2) from compound of formula (VII-2) by re-esterification, where re-esterification step is carried out in presence of base. Either a compound of formula (I-2) or a tautomer thereof of formula (Ia-2) is obtained by a method involving step (1) involving reaction of compound
and
and
to obtain compound
where R3b is isopropoxy; and R3a is H, R1 is F; R2 is Cl or Br; Z is -S-; wherein reaction at step (1) is carried out under conditions as described above for step A, then, step (2) is carried out: forming a compound of formula (X-2) from a compound of formula (V-2) by re-esterification, wherein the re-esterification step is carried out in the presence of base
and step (3): halogenation of compound with formula (X-2) to form halide; and then reacting halide and a compound of formula (VI)
or a salt thereof, to obtain a compound of formula (I-2) or formula (Ia-2). Values of radicals R1, R2, R3, R6, Y, Z are given above.
EFFECT: disclosed process is simple by mechanism of action, reduces total time of process, provides high output of end product (up to 78 %) and convenient separation of finished product, which is suitable for industrial production.
20 cl, 22 tbl, 12 ex
Title | Year | Author | Number |
---|---|---|---|
PROCESSES FOR PREPARING DIHYDROPYRIMIDINE DERIVATIVES AND INTERMEDIATE COMPOUNDS THEREOF | 2014 |
|
RU2688193C1 |
DIHYDROPYRIMIDIN COMPOUNDS AND THEIR APPLICATION IN PHARMACEUTICALS | 2013 |
|
RU2655914C9 |
DIHYDROPYRIMIDINE COMPOUNDS AND THEIR APPLICATION IN PHARMACEUTICALS | 2014 |
|
RU2678990C1 |
INDAZOLE-CARBOXAMIDE COMPOUNDS | 2005 |
|
RU2404179C2 |
NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES AND USE THEREOF IN PHARMACEUTICAL PREPARATIONS | 2013 |
|
RU2701156C2 |
METHOD OF PRODUCING BIARYLUREA AND ANALOGUES THEREOF | 2006 |
|
RU2431630C2 |
5-FLUORO-4-IMINO-3-(SUBSTITUTED)-3,4-DIHYDROPYRIMIDIN-2-(1H)-ONE DERIVATIVES, COMPOSITION BASED THEREON AND METHOD FOR CONTROLLING FUNGAL DISEASES | 2012 |
|
RU2613451C2 |
DERIVATIVES OF 2-AMINO-4H-3,1-BENZOXAZINE-4-ONE FOR PROPHYLAXIS OR TREATMENT OF OBESITY OR ACCOMPANYING DISORDER | 2000 |
|
RU2244711C2 |
ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE | 2019 |
|
RU2797622C2 |
ESTROGEN RECEPTOR PROTEOLYSIS MODULATORS AND RELATED USES THEREOF | 2018 |
|
RU2797808C2 |
Authors
Dates
2019-08-19—Published
2014-11-27—Filed